Drug-induced cataract

DRUGADVERS_CATAR

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H26.3# 1 out of 7 registries used, show all original rules.	828
4. Check minimum number of events None	828
5. Include endpoints None	828
6. Filter based on genotype QC (FinnGen only)	828

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	DRUGADVERS_CATAR
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H263
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Drug-induced cataract based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	4232	2397	1803
Only index persons	3685	2140	1545
Unadjusted period prevalence (%)
Whole population	0.06	0.07	0.05
Only index persons	0.07	0.08	0.06
Median age at first event (years)
Whole population	56.28	56.55	55.83
Only index persons	55.90	56.26	55.39

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	828	490	338
Unadjusted period prevalence (%)	0.16	0.17	0.15
Median age at first event (years)	55.09	54.31	56.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
742: Matched controls
7420

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H26.3

ICD-10 Finland

Drug-induced cataract

+∞

323.0

741

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

23.4

297.9

604

1170

Z96.1

ICD-10 Finland

Presence of intraocular lens

15.6

196.2

365

433

H02AB04

ATC

methylprednisolone; systemic

9.0

137.6

354

685

L04AX01

ATC

azathioprine; systemic

18.7

134.0

216

159

127

Kela drug reimbursment

Transplant complication

44.4

132.6

164

L04AA06

ATC

mycophenolic acid; systemic

36.0

118.0

153

L04AA01

ATC

[U] ciclosporin; systemic

42.0

116.7

146

L04AD01

ATC

ciclosporin; systemic

39.1

112.5

143

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

5.9

108.4

456

1587

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

8.6

108.1

268

456

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.5

102.0

459

1685

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

17.3

92.8

152

109

H20.1

ICD-10 Finland

Chronic iridocyclitis

60.0

92.6

108

Z94.0

ICD-10 Finland

Kidney transplant status

40.6

88.2

111

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

9.8

87.9

193

257

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.7

83.4

507

2345

H26.4

ICD-10 Finland

After-cataract

8.4

81.1

196

303

C03CA01

ATC

furosemide; systemic

4.7

75.8

343

1150

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

21.9

74.6

111

H02AB06

ATC

prednisolone; systemic

4.2

73.2

513

2567

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

6.8

70.9

201

386

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

12.2

70.1

133

130

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

21.6

69.0

103

M05BA04

ATC

alendronic acid; oral

7.7

66.3

167

268

H26.2

ICD-10 Finland

Complicated cataract

28.7

65.2

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

8.8

64.9

149

206

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.3

63.0

222

550

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

35.1

58.7

CJB10

NOMESCO Finland

Laser discission of secondary cataract

7.0

58.0

156

272

A12AA04

ATC

calcium carbonate; oral

25.1

57.2

H26.02

ICD-10 Finland

Presenil cataract

12.4

54.8

102

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

26.3

54.5

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

6.8

53.3

146

259

A11CC03

ATC

alfacalcidol; systemic

15.5

51.8

TK800

NOMESCO Finland

Hemodialysis

14.9

49.8

P01BA02

ATC

hydroxychloroquine; oral

5.6

47.7

154

334

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

3.1

47.5

408

2075

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

31.5

46.1

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

7.8

45.8

111

163

137

Kela drug reimbursment

Uraemia requiring dialysis

21.2

44.4

WX100

NOMESCO Finland

Conjunctival surface anesthesia

4.6

42.8

165

430

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

6.0

42.8

127

246

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

6.0

42.3

125

241

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.7

42.0

218

744

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

6.6

41.8

115

202

H02AB07

ATC

prednisone; oral

3.9

41.7

199

633

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.4

41.7

249

951

H02AB09

ATC

hydrocortisone; systemic

11.2

41.3

B03XA02

ATC

darbepoetin alfa; parenteral

15.1

41.0

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.1

41.0

119

224

Z49.1

ICD-10 Finland

Extracorporeal dialysis

19.0

40.9

B03XA01

ATC

erythropoietin; parenteral

37.2

40.9

J01MA12

ATC

levofloxacin; systemic

3.5

40.8

229

831

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.7

40.8

155

397

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

21.7

40.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.6

37.8

145

373

J01FF01

ATC

clindamycin; systemic

3.0

37.6

296

1354

R50.9

ICD-10 Finland

Fever, unspecified

3.8

37.5

183

588

S01ED51

ATC

timolol, combinations; ophthalmic

5.6

37.1

116

238

N18.0

ICD-10 Finland

End-stage renal disease

22.7

36.7

ZX120

NOMESCO Finland

Intravenous

4.6

35.9

138

354

B05DA

ATC

Isotonic solutions

22.3

35.8

TPH04

NOMESCO Finland

Cathetrisation of vein

3.2

35.6

238

967

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

24.3

35.3

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

35.2

297

1409

V03AE01

ATC

polystyrene sulfonate; oral

19.6

34.9

A07AA02

ATC

nystatin; oral

5.9

34.7

103

198

ZXA00

NOMESCO Finland

Right side

2.9

34.6

279

1283

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

7.8

34.1

114

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

24.3

34.0

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

29.8

33.7

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

7.7

32.9

113

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

10.7

32.5

S01BC05

ATC

ketorolac; ophthalmic

8.1

32.3

102

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.3

31.7

183

662

N18.8

ICD-10 Finland

Other chronic renal failure

10.3

31.5

A07EC01

ATC

sulfasalazine; oral, rectal

4.3

30.5

124

333

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

8.3

30.2

A02BC02

ATC

pantoprazole; systemic

2.6

29.5

545

3856

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.6

29.5

178

ZXD05

NOMESCO Finland

Urgent procedure

2.6

29.0

288

1463

XCK10

NOMESCO Finland

Photography of fundus of eye

3.9

29.0

129

376

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

18.9

28.2

H25.1

ICD-10 Finland

Senile nuclear cataract

2.8

27.8

216

945

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

8.0

27.5

H25.8

ICD-10 Finland

Other senile cataract

4.0

27.5

120

343

M04AA01

ATC

allopurinol; systemic

3.5

27.1

143

478

L88

ICPC

Rheumatoid/seropositive arthritis

6.3

26.9

128

Z2446

NOMESCO Finland

Social worker

4.5

26.9

101

250

Z49.2

ICD-10 Finland

Other dialysis

18.8

26.9

H30.2

ICD-10 Finland

Posterior cyclitis

145.3

26.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.6

26.7

135

436

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

11.3

26.4

J01MA02

ATC

ciprofloxacin; systemic

2.3

26.2

350

2047

ZXA05

NOMESCO Finland

Left side

2.6

26.2

249

1218

B07.9

ICD-10 Finland

Verruca simplex

7.1

25.9

N02AX02

ATC

tramadol; systemic, rectal

2.3

25.9

377

2293

L04AB04

ATC

adalimumab; parenteral

11.1

25.7

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

7.3

25.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.7

25.2

118

357

R03AC12

ATC

salmeterol; inhalant

6.2

25.1

123

L04AA13

ATC

leflunomide; oral

7.0

24.9

Z49.0

ICD-10 Finland

Preparatory care for dialysis

16.2

24.9

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

134.5

24.8

B05DB

ATC

Hypertonic solutions

17.1

24.7

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

6.4

24.7

114

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.5

24.7

126

409

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.7

24.4

115

350

L01AA01

ATC

cyclophosphamide; systemic

39.0

24.1

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

23.9

167

676

E0000UV

ATC

2.3

23.8

343

2051

S01EC01

ATC

acetazolamide; systemic

8.9

23.7

S01ED01

ATC

timolol; ophthalmic

6.7

23.4

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

5.3

23.3

153

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.8

23.2

104

302

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

7.2

22.8

A41.9

ICD-10 Finland

Sepsis, unspecified

7.0

22.4

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.2

22.2

128

452

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

36.3

22.2

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.5

21.9

204

969

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

21.8

149

590

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.8

21.8

165

698

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

21.8

183

823

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

15.9

21.7

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.7

21.6

100

298

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.5

21.6

107

338

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

21.5

351

2186

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

18.1

21.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.6

21.4

190

880

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.8

21.1

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.1

21.0

230

V03AE02

ATC

sevelamer; oral

25.1

21.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.0

20.8

134

510

H04.10

ICD-10 Finland

Dry eye syndrome

3.3

20.8

112

376

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

6.4

20.7

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

5.2

20.5

134

ZXA10

NOMESCO Finland

Bilateral

2.5

20.2

181

841

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.7

20.1

271

J01MA14

ATC

moxifloxacin; systemic

3.3

20.1

110

371

S01BC03

ATC

diclofenac; ophthalmic

8.4

20.0

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

5.9

19.9

104

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

75.6

19.8

7151

FHL

Kidney transplantation

107.9

19.7

Z94.4

ICD-10 Finland

Liver transplant status

41.3

19.6

A05AA02

ATC

ursodeoxycholic acid; oral

10.5

19.6

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

7.3

19.5

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.4

19.4

100

324

UJF32

NOMESCO Finland

Coloscopy

2.3

19.4

234

1256

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.3

19.4

103

342

WX002

NOMESCO Finland

Sedation and analgesia

2.4

19.3

199

988

TK810

NOMESCO Finland

Hemofiltration

23.3

19.2

J05AB11

ATC

valaciclovir; oral

2.8

19.1

135

543

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

6.2

19.1

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

19.0

245

1355

NF1AA

NOMESCO Finland

Hip X-ray examination

3.3

18.9

102

342

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.7

18.9

151

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

7.6

18.8

R03DA04

ATC

theophylline; systemic, rectal

4.9

18.5

136

A46

ICD-10 Finland

Erysipelas

2.7

18.5

143

607

UKC02

NOMESCO Finland

Cystoscopy

2.6

18.4

148

642

C08CA01

ATC

amlodipine; oral

2.1

18.2

287

1724

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.5

18.2

157

TGC00

NOMESCO Finland

Bronchial lavation

6.4

18.2

S97

ICPC

Chronic ulcer skin

4.4

18.2

167

S01FA04

ATC

cyclopentolate; ophthalmic

15.8

18.1

M81.9

ICD-10 Finland

Osteoporosis, unspecified

5.6

18.0

100

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

8.2

18.0

M01CB01

ATC

sodium aurothiomalate; parenteral

8.2

18.0

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

23.5

17.8

WX140

NOMESCO Finland

Parabulbar anesthesy

4.8

17.8

137

R06.0

ICD-10 Finland

Dyspnoea

2.2

17.8

218

1171

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.7

17.8

238

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

11.1

17.6

C07AB02

ATC

metoprolol; systemic

2.4

17.6

174

842

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

19.2

17.4

XCK00

NOMESCO Finland

Perimetry

3.7

17.3

227

WW200

NOMESCO Finland

Immunization

6.7

17.3

XG410

NOMESCO Finland

Flow-volume spirometry

4.5

17.3

151

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

15.3

17.3

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

6.0

17.2

H05BX01

ATC

cinacalcet; oral

19.8

17.0

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

16.9

128

535

GD1AD

NOMESCO Finland

Thorax CT examination

4.3

16.8

155

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.2

16.8

323

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.6

16.8

136

591

318

Kela drug reimbursment

Teriparatide

18.4

16.6

N02AA05

ATC

oxycodone; systemic

2.6

16.5

134

580

196

Kela drug reimbursment

Paricalcitol and cinacalcet

14.7

16.4

JN3AD

NOMESCO Finland

Abdominal CT examination

3.2

16.4

310

C08CA05

ATC

nifedipine; systemic

3.7

16.3

211

KA1AE

NOMESCO Finland

Kidney ultrasound examination

6.2

16.3

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

6.7

16.2

H05AA02

ATC

teriparatide; parenteral

19.0

16.1

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

14.0

16.1

205

Kela drug reimbursment

Chronic hypertension

2.1

16.0

224

1265

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.4

16.0

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

7.6

15.9

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

16.1

15.8

M05BA01

ATC

etidronic acid; systemic

34.2

15.8

R03BB04

ATC

tiotropium bromide; inhalant

2.9

15.6

364

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

5.3

15.6

C08CA02

ATC

felodipine; oral

3.0

15.6

358

M05BX04

ATC

denosumab; parenteral

4.0

15.6

167

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.2

15.5

291

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.1

15.4

102

ZX112

NOMESCO Finland

Subcutaneous

7.2

15.3

TK820

NOMESCO Finland

Peritoneal dialysis

16.5

15.3

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.3

15.3

268

M81.4

ICD-10 Finland

Drug-induced osteoporosis

29.3

15.2

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

24.0

15.2

J05AB01

ATC

aciclovir; systemic

2.2

15.2

177

920

ZXE20

NOMESCO Finland

More than three and less than five hours

2.5

15.2

132

595

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

4.2

15.2

146

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.2

14.9

148

K06.18

ICD-10 Finland

Another gingival hyperplasia

25.6

14.7

WW500

NOMESCO Finland

Blood transfusion

4.6

14.6

117

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

14.6

194

1066

JJC00

NOMESCO Finland

Allogenic transplantation of liver

81.8

14.6

J01DB01

ATC

cefalexin; oral

2.1

14.6

620

5226

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

8.1

14.5

SPAT1263

SPAT

Sampling

1.9

14.4

334

2264

M05BB03

ATC

alendronic acid and colecalciferol; oral

6.3

14.4

CS494

NOMESCO Finland

Other visual field testing

5.9

14.4

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

11.7

14.4

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

27.8

14.3

ZX108

NOMESCO Finland

Inhalation

13.7

14.3

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

7.2

14.3

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

6.2

13.9

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.4

13.9

217

R03AC13

ATC

formoterol; inhalant

3.7

13.9

179

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.3

13.8

235

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

13.8

399

2901

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

9.3

13.8

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

10.0

13.8

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

13.8

146

724

114

Kela drug reimbursment

Glaucoma

3.0

13.7

283

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.2

13.7

258

A12BA01

ATC

potassium chloride; oral

4.4

13.6

121

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

76.6

13.6

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

13.6

324

2203

E000001

ATC

2.1

13.5

174

942

J46

ICD-10 Finland

Status asthmaticus

5.6

13.5

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

5.9

13.5

M05BA07

ATC

risedronic acid; oral

4.6

13.4

104

SPAT1229

SPAT

Assessment of need for aid

3.0

13.4

285

A02BC01

ATC

omeprazole; systemic

2.0

13.4

220

1312

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

7.5

13.4

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

8.8

13.3

Z94.2

ICD-10 Finland

Lung transplant status

40.9

13.2

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

15.4

13.2

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.7

13.1

377

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

17.1

13.0

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

28.9

13.0

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

28.9

13.0

B01AA03

ATC

warfarin; systemic

2.2

13.0

143

719

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

19.5

13.0

J45.8

ICD-10 Finland

Mixed asthma

5.3

12.9

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

14.4

12.8

J01FA06

ATC

roxithromycin; oral

1.8

12.8

320

2202

J01DA01

ATC

[U] cefalexin; systemic

1.8

12.7

471

3665

J01EA01

ATC

trimethoprim; systemic

2.0

12.7

192

1102

P01AB01

ATC

metronidazole; oral, rectal

1.8

12.7

304

2060

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

12.6

153

804

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

12.6

272

1778

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

12.6

137

686

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.9

12.6

305

H02AB08

ATC

triamcinolone; systemic

17.7

12.6

L04AA17

ATC

[U] adalimumab; parenteral

17.7

12.6

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

9.5

12.6

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

24.8

12.5

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.1

12.5

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

7.1

12.5

C09AA02

ATC

enalapril; systemic

2.1

12.5

157

835

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

132.2

12.5

N03AX16

ATC

pregabalin; oral

2.0

12.4

192

1111

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.9

12.4

C02CA01

ATC

prazosin; oral

8.2

12.4

ZZA00

NOMESCO Finland

Split skin graft

5.0

12.4

U14

ICPC

Kidney symptom/complaint

7.6

12.3

SPAT1254

SPAT

Administration of medicine

2.3

12.3

121

576

WX199

NOMESCO Finland

Other local analgesia

5.4

12.3

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.2

12.2

210

L01BB01

ATC

38.2

12.2

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

38.2

12.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.3

12.2

194

C07AB07

ATC

bisoprolol; oral

1.8

12.0

342

2433

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.9

12.0

132

R60.0

ICD-10 Finland

Localized oedema

2.5

12.0

100

439

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.9

12.0

266

J01CF02

ATC

cloxacillin; systemic

6.0

11.9

S01EC04

ATC

brinzolamide; ophthalmic

4.3

11.9

108

K65.0

ICD-10 Finland

Acute peritonitis

8.6

11.9

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

5.2

11.8

B99

ICD-10 Finland

Other and unspecified infectious diseases

6.8

11.8

S01EA03

ATC

apraclonidine; ophthalmic

10.8

11.8

C08CA03

ATC

isradipine; systemic

9.1

11.8

B02.9

ICD-10 Finland

Zoster without complication

3.3

11.8

193

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

11.7

262

1723

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.5

11.7

161

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

16.7

11.7

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

16.7

11.7

A02BA02

ATC

ranitidine; systemic

2.0

11.7

161

888

R03BA02

ATC

budesonide; inhalant

2.1

11.7

150

804

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

30.6

11.7

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

19.3

11.6

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

11.6

110

514

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.3

11.6

101

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

23.3

11.6

J02AC01

ATC

fluconazole; systemic

1.8

11.6

295

2021

XCH00

NOMESCO Finland

Eye pressure measurement

4.0

11.6

121

S18

ICPC

Laceration/cut

1.7

11.5

325

2297

AA1AD

NOMESCO Finland

CT of head and brain

1.9

11.4

183

1071

RS220

NOMESCO Finland

7.1

11.4

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

12.1

11.4

TNG10

NOMESCO Finland

Puncture of knee

8.5

11.4

H43.1

ICD-10 Finland

Vitreous haemorrhage

5.3

11.3

R11

ICD-10 Finland

Nausea and vomiting

2.8

11.3

282

C07AG02

ATC

carvedilol; oral

3.2

11.3

205

I50.9

ICD-10 Finland

Heart failure, unspecified

2.5

11.3

406

C03DA01

ATC

spironolactone; oral

2.5

11.2

419

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

25.5

11.2

L04AA11

ATC

[U] etanercept; parenteral

20.4

11.2

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.5

11.1

J01CA04

ATC

amoxicillin; systemic

1.9

11.1

599

5121

D86.0

ICD-10 Finland

Sarcoidosis of lung

7.2

11.1

TQW99

NOMESCO Finland

Other minor procedure on skin

3.5

11.1

152

A07EA06

ATC

budesonide; oral, local oral

4.1

11.1

106

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

11.1

111

533

WZA10

NOMESCO Finland

Long statement of health and health related matters

7.6

11.0

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

11.0

143

770

H40.0

ICD-10 Finland

Glaucoma suspect

2.8

11.0

282

602

Kela drug reimbursment

Children's severe malnutrition

44.0

10.9

R03AC02

ATC

salbutamol; inhalant

1.7

10.9

390

2937

M45

ICD-10 Finland

Ankylosing spondylitis

5.5

10.8

J45.1

ICD-10 Finland

Nonallergic asthma

2.8

10.8

271

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

10.8

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

10.8

218

1378

N03AX12

ATC

gabapentin; oral

2.1

10.8

129

671

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

2.2

10.8

120

602

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.1

10.8

104

L04AA05

ATC

[U] tacrolimus; systemic

28.5

10.8

A02BC05

ATC

esomeprazole; systemic

1.7

10.7

309

2182

EBA10

NOMESCO Finland

Surgical removal of tooth

2.4

10.7

430

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

21.8

10.7

XW000

NOMESCO Finland

Bone marrow biopsy

3.8

10.7

125

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

60.9

10.6

GDG10

NOMESCO Finland

Bilateral transplantation of lung

60.9

10.6

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

10.6

224

1437

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

3.3

10.6

164

TQW11

NOMESCO Finland

Vacuum treatment of wound

6.0

10.5

B01AB05

ATC

enoxaparin; parenteral

1.8

10.5

231

1499

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

3.1

10.5

203

SPAT1262

SPAT

Handing over of treatment supplies

2.0

10.4

152

855

JJ5AT

NOMESCO Finland

111.5

10.4

M13.9

ICD-10 Finland

Arthritis, unspecified

2.8

10.4

265

Z3226

NOMESCO Finland

Physiotherapist

2.0

10.4

155

880

NH3EA

NOMESCO Finland

Feet X-ray examination with load

5.7

10.4

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

33.0

10.4

6BA02

NOMESCO Finland

33.0

10.4

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.2

10.3

107

522

K83.0

ICD-10 Finland

Cholangitis

9.0

10.3

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

10.3

343

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

10.8

10.3

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.0

10.3

C08CA13

ATC

lercanidipine; oral

2.2

10.3

111

552

XG466

NOMESCO Finland

Sleep oxymetry

3.8

10.3

114

C02EA02

ATC

4.1

10.3

R03BB01

ATC

ipratropium bromide; inhalant

4.1

10.3

A07AA09

ATC

vancomycin; oral

7.6

10.2

SPAT1325

SPAT

Vaccination

1.7

10.2

253

1701

JN4BD

NOMESCO Finland

Extensive body CT

2.3

10.2

460

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.1

10.2

186

A06AD11

ATC

lactulose; oral

2.2

10.2

107

523

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

10.1

277

1920

R31

ICD-10 Finland

Unspecified haematuria

2.6

10.1

322

RD210

NOMESCO Finland

5.4

10.1

N19

ICD-10 Finland

Unspecified kidney failure

4.1

10.1

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.9

10.0

R03DC03

ATC

montelukast; oral

2.0

10.0

140

773

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

10.0

117

601

R4110

NOMESCO Finland

Physiotherapy

1.8

10.0

210

1341

5AB14

NOMESCO Finland

40.6

10.0

C02AC05

ATC

moxonidine; oral

3.5

10.0

138

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

4.0

9.9

102

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

17.0

9.9

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

9.7

9.8

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.6

9.8

302

R03AC03

ATC

terbutaline; inhalant

2.1

9.8

117

606

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

9.7

424

SPAT1211

SPAT

Application of soft bandage

2.5

9.7

328

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

6.9

9.7

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

55.7

9.7

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

55.7

9.7

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.2

9.7

164

R03BA08

ATC

ciclesonide; inhalant

2.5

9.7

329

H33.0

ICD-10 Finland

Retinal detachment with retinal break

4.3

9.6

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

3.7

9.6

116

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.9

9.6

216

H15.1

ICD-10 Finland

Episcleritis

7.3

9.6

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

10.2

9.6

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.0

9.5

V03AE03

ATC

lanthanum carbonate; oral

15.3

9.5

WX202

NOMESCO Finland

Supraclavicular plexus blockade

6.7

9.5

A02BC03

ATC

lansoprazole; oral

1.7

9.4

218

1430

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

101.3

9.4

5602

FHL

Internal fistula (eg Cimino)

101.3

9.4

NDB60

NOMESCO Finland

Prosthetic replacement of MCP joint of finger

101.3

9.4

M33.2

ICD-10 Finland

Polymyositis

101.3

9.4

Z94.1

ICD-10 Finland

Heart transplant status

17.8

9.4

Z3231

NOMESCO Finland

Registered nurse

1.8

9.4

205

1322

NDG30

NOMESCO Finland

Fusion of wrist, total

12.5

9.4

R4180

NOMESCO Finland

Podiatric therapy

8.2

9.4

M10.9

ICD-10 Finland

Gout, unspecified

2.8

9.4

227

M31.3

ICD-10 Finland

Wegener granulomatosis

22.0

9.4

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.0

9.3

191

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.5

9.3

124

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

3.1

9.3

163

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

4.0

9.2

L28

ICPC

Limited function/disability (L)

2.1

9.2

117

619

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

6.8

9.2

NHQ40

NOMESCO Finland

Amputation of toe

6.4

9.1

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

9.1

165

998

S01EE03

ATC

bimatoprost; ophthalmic

4.8

9.1

L04AB01

ATC

etanercept; parenteral

6.0

9.1

XPX08

NOMESCO Finland

Intraoperative flow measurement

11.7

9.1

N05CF01

ATC

zopiclone; oral

1.7

9.1

223

1485

X58

ICD-10 Finland

Exposure to other specified factors

2.1

9.1

110

571

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

15.8

9.1

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

37.2

9.0

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

37.2

9.0

Z99.2

ICD-10 Finland

Dependence on renal dialysis

37.2

9.0

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

37.2

9.0

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

9.0

416

R03DC01

ATC

zafirlukast; oral

5.4

9.0

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

8.9

165

1005

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

24.3

8.9

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

24.3

8.9

N06AA09

ATC

amitriptyline; systemic

2.2

8.9

432

ZXE00

NOMESCO Finland

One hour or less

1.6

8.9

291

2099

WZC30

NOMESCO Finland

Teaching

2.0

8.9

115

615

S01EE01

ATC

latanoprost; ophthalmic

2.9

8.9

192

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

12.7

8.9

CKC12

NOMESCO Finland

Photocoagulation of retina

3.2

8.8

152

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

5.2

8.8

I15.0

ICD-10 Finland

Renovascular hypertension

10.9

8.8

A02BA03

ATC

famotidine; systemic

3.6

8.8

114

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.3

8.8

J96.1

ICD-10 Finland

Chronic respiratory failure

5.0

8.8

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

8.8

416

L95

ICPC

Osteoporosis

4.1

8.7

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

8.7

155

931

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

50.6

8.7

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

7.8

8.7

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

7.8

8.7

NG4AA

NOMESCO Finland

Lower leg X-ray examination

4.0

8.6

XF600

NOMESCO Finland

Bloodpressure measurement

2.7

8.6

233

Z3229

NOMESCO Finland

Other healthcare associate professional

2.4

8.6

343

M81.8

ICD-10 Finland

Other osteoporosis

11.7

8.6

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

16.5

8.6

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

16.5

8.6

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

9.1

8.6

S01FA02

ATC

scopolamine; ophthalmic

9.1

8.6

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.3

8.5

357

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

27.9

8.5

RS221

NOMESCO Finland

5.8

8.5

J01MA01

ATC

ofloxacin; systemic

2.5

8.5

285

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

7.5

8.5

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.6

8.5

239

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

3.7

8.4

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

4.0

8.4

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

4.6

8.4

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

91.1

8.4

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

91.1

8.4

KAC00

NOMESCO Finland

Nephrectomy

12.9

8.4

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.8

8.4

199

JN4AD

NOMESCO Finland

Body CT examination

2.4

8.3

301

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

+∞

8.3

187

Kela drug reimbursment

MPA

+∞

8.3

PC6DE

NOMESCO Finland

+∞

8.3

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

3.2

8.3

136

SPAT1216

SPAT

Assessment of functional ability

2.0

8.3

111

602

A07EC02

ATC

mesalazine; oral, rectal

2.7

8.3

207

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

8.3

134

779

R01AD08

ATC

fluticasone; nasal

1.7

8.3

212

1424

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.5

8.3

283

H26.9

ICD-10 Finland

Cataract, unspecified

5.2

8.2

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

14.7

8.2

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.8

8.2

196

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

4.3

8.2

D06BB04

ATC

podophyllotoxin; topical

3.1

8.2

144

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.8

8.2

189

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.9

8.1

173

M05BA06

ATC

ibandronic acid; systemic

4.9

8.1

L73.8

ICD-10 Finland

Other specified follicular disorders

8.3

8.1

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

33.7

8.1

NDG74

NOMESCO Finland

Fusion of first IP joint

17.4

8.1

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

9.1

8.1

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

8.0

140

836

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

8.0

362

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

7.4

8.0

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.7

7.9

194

JAF10

NOMESCO Finland

Repair of umbilical hernia

4.6

7.9

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.5

7.9

249

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

13.2

7.9

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

13.2

7.9

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.2

7.9

125

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

5.5

7.9

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.2

7.9

131

H11.3

ICD-10 Finland

Conjunctival haemorrhage

3.1

7.8

137

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.5

7.8

252

A28

ICPC

Limited function/disability NOS

2.0

7.8

101

538

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.9

7.8

166

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

7.1

7.8

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

9.5

7.8

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.6

7.8

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

4.2

7.8

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.5

7.7

58209

ICD-8 Finland

Chronic nephritis, Unspecified

45.5

7.7

H40.8

ICD-10 Finland

Other glaucoma

45.5

7.7

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

7.7

296

2202

WX882

NOMESCO Finland

High dependency care

3.6

7.7

N02AC04

ATC

dextropropoxyphene; oral

3.4

7.6

106

H16.9

ICD-10 Finland

Keratitis, unspecified

5.0

7.6

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

7.6

163

1034

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

7.6

179

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

18.6

7.6

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

7.6

277

2031

TQW40

NOMESCO Finland

Remowal of suture of skin

2.4

7.6

290

N30.9

ICD-10 Finland

Cystitis, unspecified

3.0

7.6

149

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.8

7.6

180

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

7.6

451

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

7.6

262

L04AB06

ATC

golimumab; parenteral

9.0

7.6

132

Kela drug reimbursment

Sarcoidosis

9.0

7.6

A04AA01

ATC

ondansetron; systemic, rectal

2.4

7.5

263

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.7

7.5

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.9

7.5

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.8

7.5

174

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

80.9

7.4

M31.7

ICD-10 Finland

Microscopic polyangiitis

80.9

7.4

ZX197

NOMESCO Finland

80.9

7.4

212

Kela drug reimbursment

Gout

5.4

7.4

C90.0

ICD-10 Finland

Multiple myeloma

6.1

7.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

7.4

453

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.8

7.4

167

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

7.4

336

2596

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.9

7.3

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.9

7.3

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

6.9

7.3

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

11.0

7.3

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.3

7.3

110

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

9.5

7.3

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

+∞

7.3

M33.1

ICD-10 Finland

Other dermatomyositis

+∞

7.3

KAS40

NOMESCO Finland

Excision of transplanted kidney

+∞

7.3

ZY010

NOMESCO Finland

Hospital outpatient

2.9

7.3

156

WX204

NOMESCO Finland

Axillary plexus blockaced

3.2

7.3

116

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

5.9

7.3

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

7.2

422

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

7.4

7.2

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

30.3

7.2

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

30.3

7.2

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

30.3

7.2

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

30.3

7.2

L01AA02

ATC

chlorambucil; oral

30.3

7.2

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

5.1

7.1

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

20.2

7.1

XX4BW

NOMESCO Finland

20.2

7.1

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

8.0

7.1

R06AE07

ATC

cetirizine; oral

1.5

7.1

308

2348

RJ411

NOMESCO Finland

8.9

7.1

1XC02

NOMESCO Finland

8.9

7.1

N06AB04

ATC

citalopram; systemic

1.7

7.1

155

989

A01AB09

ATC

miconazole; local oral

2.2

7.1

342

N30.0

ICD-10 Finland

Acute cystitis

1.9

7.1

101

559

H10.4

ICD-10 Finland

Chronic conjunctivitis

10.2

7.1

L03AA02

ATC

filgrastim; parenteral

3.9

7.0

SPAT1234

SPAT

Support of social functional capacity

3.0

7.0

131

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

7.0

205

1419

SPAT1301

SPAT

No procedures

1.6

7.0

219

1542

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

6.9

123

736

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.7

6.9

173

R03BA05

ATC

fluticasone; inhalant

1.8

6.9

134

824

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.0

6.9

L82

ICD-10 Finland

Seborrhoeic keratosis

1.8

6.9

118

698

SPAT1255

SPAT

Intravenous administration of medicine

2.4

6.9

237

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

13.9

6.9

H01AC01

ATC

somatropin; parenteral

13.9

6.9

S01AX11

ATC

[U] ofloxacin; ophthalmic

3.3

6.9

104

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

6.8

467

R4190

NOMESCO Finland

Nutritional therapy

3.0

6.8

122

WX892

NOMESCO Finland

Monitored bed care

2.3

6.8

285

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

11.1

6.8

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

11.1

6.8

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

6.8

169

1120

H3603, E103

ICD-10 Finland

6.2

6.8

N03.1

ICD-10 Finland

Chronic nephritic syndrome, focal and segmental glomerular lesions

40.4

6.8

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

40.4

6.8

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

16.9

6.8

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

16.9

6.8

S01KA02

ATC

hypromellose; ophthalmic

4.8

6.8

L57.0

ICD-10 Finland

Actinic keratosis

2.2

6.7

336

K03.66

ICD-10 Finland

Tooth plaque

2.4

6.7

246

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

7.3

6.7

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

4.5

6.7

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

22.7

6.7

V03AG01

ATC

sodium cellulose phosphate; systemic

22.7

6.7

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

6.5

6.7

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

4.3

6.7

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

6.0

6.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

6.6

304

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

6.6

142

J01CA08

ATC

pivmecillinam; oral

1.5

6.6

264

1965

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.0

6.6

125

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.7

6.6

166

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

12.4

6.6

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

12.4

6.6

5BA08

NOMESCO Finland

8.8

6.6

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

10.1

6.5

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

10.1

6.5

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

10.1

6.5

321

Kela drug reimbursment

Paricalcitol and cinacalcet

10.1

6.5

SPAT1153

SPAT

Removal of sutures

1.6

6.5

234

1698

R03AK08

ATC

formoterol and beclometasone; inhalant

2.9

6.5

130

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

2.9

6.5

130

J20

ICD-10 Finland

Acute bronchitis

2.0

6.5

406

R51.80

ICD-10 Finland

Headache

1.8

6.5

104

602

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

3.2

6.5

104

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

4.8

6.4

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.6

6.4

180

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.7

6.4

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.7

6.4

NDC40

NOMESCO Finland

Secondary prosthetic replacement in of joint of finger or metacarpal

70.4

6.4

A14AB01

ATC

nandrolone; parenteral

70.4

6.4

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

7.5

6.4

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

6.4

535

5958

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

3.4

6.4

R06.2

ICD-10 Finland

Wheezing

2.7

6.4

155

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

14.5

6.4

E000003

ATC

2.8

6.4

139

D01AE16

ATC

amorolfine; topical

1.9

6.4

475

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

5.0

6.4

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

8.2

6.3

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

6.3

336

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.7

6.3

CJE15

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

11.1

6.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

6.3

114

684

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

9.4

6.3

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.5

6.3

203

TFJ02

NOMESCO Finland

Muscle biopsy of heart

18.2

6.3

9531

FHL

Arthrodesis of the hand joint

18.2

6.3

5828B

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,NEFR SDR]

+∞

6.3

9968A

ICD-9 Finland

Complications peculiar to certain specified procedures, Complications of transplanted organ

+∞

6.3

M79.6

ICD-10 Finland

Pain in limb

1.5

6.2

248

1838

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

6.2

109

650

NDL52

NOMESCO Finland

Tenosynovectomy of hand

7.1

6.2

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

26.9

6.2

M31.1

ICD-10 Finland

Thrombotic microangiopathy

26.9

6.2

H25.0

ICD-10 Finland

Senile incipient cataract

2.4

6.2

216

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.0

6.2

113

J01FA10

ATC

azithromycin; systemic

1.5

6.2

414

3425

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

6.2

225

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.5

6.2

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

6.2

346

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.8

6.2

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.3

6.2

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

6.2

251

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

7.8

6.1

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

7.8

6.1

K50.8

ICD-10 Finland

Other Crohn disease

4.7

6.1

K51.5

ICD-10 Finland

Left sided colitis

3.3

6.1

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

6.1

378

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

6.1

252

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.9

6.1

124

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.1

6.1

103

RJ420

NOMESCO Finland

12.6

6.1

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

6.1

174

D07AB08

ATC

desonide; topical

2.0

6.1

410

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

8.7

6.1

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

6.1

181

1254

D11AH01

ATC

tacrolimus; topical

6.8

6.1

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

10.1

6.0

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

10.1

6.0

P01BA01

ATC

chloroquine; systemic

10.1

6.0

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

5.2

6.0

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

6.1

6.0

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

6.0

164

1111

CKD40

NOMESCO Finland

Endophotocoagulation of retina

4.6

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3010375) cycloSPORINE [Mass/volume] in Blood

109

48.13

184.49

33.8

28.1

ug/l

110.2

141.6

1.04

(3026250) Tacrolimus [Mass/volume] in Blood

103

37.80

163.87

37.0

30.5

ug/l

7.2

0.05

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

150

138

13.05

144.78

15.7

6.9

iu/ml

723.0

185.6

1.15

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

126

104

14.11

129.69

6.9

3.4

u/ml

365.1

749.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

251

592

5.65

105.27

26.5

7.1

mmol/l

12.1

9.0

5.08

243

567

(3003458) Phosphate [Moles/volume] in Serum or Plasma

305

919

4.67

94.01

21.5

5.4

mmol/l

1.1

1.0

1.95

292

852

(42870588) Differential panel, method unspecified - Blood

519

2397

4.12

86.51

17.5

5.8

—

(3042733) HLA Ab [Presence] in Serum

27.04

83.66

5.3

4.0

—

(40768446) Kidney Pathology biopsy report

23.45

80.61

2.4

1.5

—

(3006315) Basophils [#/volume] in Blood

640

3544

4.55

79.38

17.5

5.8

e9/l

0.0

0.25

604

3059

(3001604) Monocytes [#/volume] in Blood

637

3529

4.49

78.61

17.4

5.8

e9/l

0.6

3.11

599

3037

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

208

532

4.89

77.36

10.4

3.9

ng/l

146.9

80.5

3.20

188

477

(3013115) Eosinophils [#/volume] in Blood

648

3660

4.54

77.13

18.3

6.2

e9/l

0.2

1.00

606

3217

(3019198) Lymphocytes [#/volume] in Blood

641

3601

4.45

76.68

17.7

5.9

e9/l

1.8

1.9

2.29

606

3164

(3005719) IgG [Mass/volume] in Serum or Plasma

208

554

4.68

73.26

6.4

2.6

g/l

8.9

10.5

5.16

200

506

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

124

209

6.80

72.54

14.4

3.9

mg/l

2.0

1.4

5.57

119

191

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

243

749

4.18

70.31

6.5

4.5

u/l

241.5

249.0

0.26

233

710

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

189

482

4.79

70.07

12.0

3.8

kpa

5.0

5.1

2.61

181

454

(3009343) pH of Capillary blood

187

475

4.79

69.64

12.2

3.8

7.4

0.11

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

182

460

4.79

68.10

12.1

3.7

mmol/l

0.9

2.0

2.83

145

349

(3019069) Monocytes/100 leukocytes in Blood

595

3349

3.76

66.76

19.0

6.3

8.7

8.6

0.34

572

3147

(3006504) Eosinophils/100 leukocytes in Blood

593

3333

3.75

66.63

18.3

6.0

2.6

2.9

3.29

569

3113

(3022948) Iron [Moles/volume] in Serum or Plasma

284

1019

3.72

65.43

6.0

2.4

umol/l

11.7

13.4

4.13

273

941

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

128

8.06

65.22

2.6

1.5

u/ml

116.7

109.2

0.25

(3002030) Lymphocytes/100 leukocytes in Blood

599

3419

3.72

64.98

18.5

6.1

25.7

28.4

8.83

577

3194

(3018010) Neutrophils/100 leukocytes in Blood

593

3366

3.68

64.84

17.2

5.9

59.8

56.6

8.71

569

3165

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

20.40

64.57

3.2

2.3

u/ml

47024.2

88660.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

145

7.53

64.50

2.6

1.5

—

(3022096) Basophils/100 leukocytes in Blood

577

3228

3.60

64.39

18.5

6.0

0.7

0.20

556

3020

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

178

463

4.62

64.01

2.6

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

243

808

3.84

62.36

2.8

1.6

—

(3023368) Bacteria identified in Blood by Culture

399

1817

3.31

62.16

8.5

4.2

—

(3042936) Bacteria identified in Isolate by Culture

277

1007

3.63

62.13

3.6

2.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

289

1081

3.57

62.00

3.0

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

662

4101

4.06

61.70

22.9

9.4

e9/l

4.4

4.0

5.52

632

3583

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

38.68

59.68

8.3

7.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

149

7.07

59.18

1.9

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

10.34

59.09

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

261

943

3.58

58.68

6.3

2.3

g/l

2.2

2.3

3.48

251

877

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

9.95

58.23

2.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

249

879

3.62

57.94

6.6

2.4

22.3

23.3

0.41

229

758

(3022313) Gas panel - Capillary blood

147

355

4.82

57.66

12.6

3.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

142

6.99

55.68

2.0

1.3

u/ml

294.4

283.3

0.10

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

548

3167

3.16

53.85

20.8

6.0

mmol/l

1.2

2.01

512

2885

(3028026) IgM [Mass/volume] in Serum or Plasma

162

447

4.26

53.37

2.9

1.7

g/l

1.3

0.21

151

408

(3027945) Reticulocytes/100 erythrocytes in Blood

216

731

3.64

53.14

6.0

2.7

1.8

0.09

198

660

(3008757) Leukocyte morphology finding [Identifier] in Blood

9.14

53.11

5.3

3.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

8.38

53.06

1.1

—

(3024471) HLA-A [Type]

19.18

52.86

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

105

205

5.72

52.39

4.0

3.0

u/ml

0.3

1.37

106

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

576

3466

3.17

51.87

24.6

6.8

mmol/l

1.2

0.36

516

2964

(3024932) HLA-DR beta [Type]

18.70

51.01

1.1

1.0

—

(3023520) Reticulocytes [#/volume] in Blood

176

533

3.92

50.83

5.2

2.7

e9/l

70.4

72.5

0.31

144

401

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

120

273

4.97

50.31

2.1

2.0

g/l

1.5

0.26

107

240

(3024561) Albumin [Mass/volume] in Serum or Plasma

515

2951

2.97

49.94

14.4

4.7

g/l

34.2

35.8

8.25

488

2754

(3017181) Myelocytes/100 leukocytes in Blood

185

590

3.75

49.47

7.3

4.2

0.6

1.0

1.45

177

(3012095) Magnesium [Moles/volume] in Serum or Plasma

279

1153

3.14

49.16

10.6

3.4

mmol/l

0.8

2.01

266

1082

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

507

2906

2.92

48.68

4.5

2.3

nmol/l

79.1

77.6

0.60

469

2588

(3002179) Metamyelocytes/100 leukocytes in Blood

172

530

3.83

48.29

6.7

4.2

0.6

0.5

0.36

124

(3004809) Band form neutrophils/100 leukocytes in Blood

110

7.29

48.24

5.0

3.2

1.0

1.2

0.39

(3021440) Promyelocytes/100 leukocytes in Blood

176

556

3.75

47.60

7.2

4.3

0.1

1.59

160

(3014148) Varicella zoster virus Ab [Titer] in Serum

8.06

47.29

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

121

299

4.57

45.70

3.0

1.4

u/ml

29.8

7.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

343

1659

2.82

44.58

3.3

2.1

mg/l

3.6

3.1

2.85

305

1417

(3019225) pH of Specimen

196

691

3.41

44.55

12.8

4.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

364

1821

2.78

44.25

6.7

2.6

umol/l

2472.8

7443.6

1.93

336

1582

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

175

5.58

43.89

3.5

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

109

258

4.71

43.36

3.5

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

178

5.48

43.06

3.4

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

100

222

4.99

42.96

2.0

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

201

740

3.27

42.39

2.7

1.6

—

(3037121) Protein [Mass/volume] in Urine

108

260

4.63

42.03

8.5

3.5

g/l

0.5

0.2

1.66

108

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

222

4.93

42.00

2.6

1.5

g/l

0.2

1.00

209

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

103

244

4.68

40.86

2.3

1.6

titre

381.8

134.0

—

(3000850) Epithelial cells [#/volume] in Urine

304

1434

2.77

40.78

6.4

2.4

e6/l

4.6

5.4

0.41

283

1272

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

7.40

40.76

3.0

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

100

232

4.77

40.70

2.5

1.5

g/l

1.1

1.2

0.86

218

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

338

1684

2.70

40.68

4.4

2.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

19.54

40.66

1.4

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

218

4.85

40.08

2.1

1.6

iu/ml

0.8

0.1

0.73

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

13.79

39.32

4.4

2.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

132

5.97

39.26

3.3

1.8

—

(40761535) Cells panel - Urine sediment

163

557

3.40

38.54

8.8

3.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

8.66

38.43

1.5

1.3

g/l

0.3

0.4

0.28

(3028192) IgG subclass 2 [Mass/volume] in Serum

8.66

38.43

1.5

1.3

g/l

2.6

2.7

0.10

(3027135) IgG subclass 1 [Mass/volume] in Serum

8.66

38.43

1.5

1.3

g/l

5.6

7.0

0.92

(3002032) Base excess in Venous blood by calculation

180

656

3.23

38.29

13.8

3.6

mmol/l

1.4

2.0

1.31

150

524

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

434

2495

2.55

38.19

10.4

3.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

240

4.55

38.09

2.7

1.8

—

(4062490)

8.38

37.44

1.5

1.3

—

(3000991) Gas panel - Venous blood

167

590

3.29

37.33

15.1

8.8

—

(3025159) Blasts/100 leukocytes in Blood

155

525

3.40

37.08

6.8

4.4

0.0

0.8

0.63

134

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

7.39

36.85

3.1

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

216

893

2.92

36.69

2.7

1.6

—

(3011412) CD3 cells [#/volume] in Blood

8.34

36.56

3.7

2.1

e9/l

1.2

0.08

(3021447) Carbon dioxide [Partial pressure] in Venous blood

178

663

3.15

36.35

13.9

3.6

kpa

5.7

5.8

0.57

172

641

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

559

3675

2.60

36.15

13.9

6.6

umol/l

9.8

11.1

3.79

538

3495

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

180

4.95

35.56

2.1

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

8.92

35.53

1.5

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

123

371

3.72

35.05

15.8

3.6

mmol/l

23.5

24.2

1.59

112

339

(3037522) Nuclear Ab [Titer] in Serum

222

955

2.81

34.81

1.6

1.3

titre

716.9

500.1

0.78

215

(3020630) Protein [Mass/volume] in Serum or Plasma

154

544

3.25

34.25

3.2

2.9

g/l

64.7

66.9

2.89

146

496

(3017354) Segmented neutrophils/100 leukocytes in Blood

7.71

34.24

4.4

3.2

62.7

55.0

1.04

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

236

4.31

33.65

2.7

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

104

6.14

33.63

1.8

g/l

0.5

0.9

1.52

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

8.50

32.73

3.6

2.1

e6/l

676.7

591.8

0.30

(44790047)

6.47

32.62

2.7

1.6

—

(44806118)

6.47

32.62

2.7

1.6

—

(44790048)

6.47

32.62

2.7

1.6

—

(44790049)

6.47

32.62

2.7

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

713

5424

3.26

32.55

22.5

7.7

u/l

75.7

78.3

0.88

687

5090

(3044640) Blood type and Crossmatch panel - Blood

384

2206

2.38

32.25

5.2

2.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

12.29

31.80

3.5

1.9

ug/l

64.2

73.2

0.12

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

222

4.26

31.20

3.6

2.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

168

658

2.95

31.04

3.4

2.1

nmol/l

270.7

369.0

7.08

160

612

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

159

4.86

30.93

1.4

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

6.21

30.77

8.5

5.9

mg/l

12.7

11.4

1.35

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

132

5.26

30.76

2.2

1.6

—

(3032080) INR in Blood by Coagulation assay

446

2792

2.29

29.92

12.8

8.3

inr

1.2

0.21

100

808

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

13.77

29.79

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

14.66

29.76

4.1

2.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

14.66

29.76

1.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

627

4557

2.55

29.51

10.3

4.2

e6/l

56.6

1785.3

0.95

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

281

3.78

29.16

2.6

1.9

ug/l

3.1

2.4

0.18

258

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

101

5.76

29.01

2.1

1.6

—

(3018418) pH of Serum or Plasma

356

2051

2.29

28.87

14.4

3.9

7.4

0.21

375

(3037467) Urinalysis macro (dipstick) panel - Urine

645

4775

2.59

28.73

12.8

4.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

20.52

28.50

2.6

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

131

469

3.13

28.19

1.8

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

681

5198

2.75

28.04

12.3

4.1

mm/h

16.8

12.0

11.29

635

4810

(3013826) Glucose [Moles/volume] in Serum or Plasma

576

4090

2.34

27.58

12.4

4.7

mmol/l

6.6

6.7

0.21

558

3833

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

106

5.49

27.54

2.6

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

128

460

3.11

27.33

3.2

2.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

226

3.97

27.20

3.8

2.5

95.2

91.3

0.53

215

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

101

315

3.51

27.14

3.7

2.1

u/l

38.2

39.4

0.21

280

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

178

768

2.68

27.09

2.5

1.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

146

568

2.91

27.07

4.1

2.6

ml/min/173m2

51.9

69.3

5.56

225

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

6.58

26.77

3.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

6.58

26.77

3.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

6.58

26.77

3.4

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

177

766

2.67

26.75

2.4

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

166

4.44

26.64

1.8

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

369

2220

2.19

26.27

5.0

2.5

u/l

58.9

58.2

0.06

344

2048

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

5.54

25.90

2.0

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

334

1947

2.20

25.58

4.5

3.1

ng/l

2023.2

1027.2

1.76

303

1642

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

5.42

25.33

2.0

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

5.42

25.33

2.0

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

361

2184

2.16

25.02

6.7

3.1

mmol/l

6.3

7.6

8.41

327

1835

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

111

387

3.16

24.87

1.8

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

233

1183

2.35

24.78

1.9

1.7

nmol/l

1166.1

1177.5

0.05

184

884

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

6.36

24.76

1.6

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

5.31

24.29

2.0

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

5.31

24.29

2.0

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

442

2914

2.11

24.18

6.0

2.7

ug/l

182.0

130.4

2.64

417

2688

(3005988) Vibrio sp identified in Specimen by Organism specific culture

100

5.26

24.02

2.0

1.4

—

(3012516) Albumin [Mass/volume] in Urine

340

2034

2.14

24.01

6.2

3.2

mg/l

615.0

215.9

0.77

256

1265

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

281

1560

2.21

24.01

2.5

1.8

mg/l

1.5

1.2

0.78

219

1197

(3037692) Legionella sp identified in Specimen by Organism specific culture

9.63

23.63

2.3

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

215

1080

2.34

23.26

2.8

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

6.22

23.13

2.9

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

373

2339

2.08

22.99

5.5

3.5

mmol/l

2.3

2.4

1.99

326

2044

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

476

3266

2.08

22.93

7.2

3.9

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

133

4.53

22.84

5.7

3.0

e9/l

4.5

0.01

133

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

138

4.44

22.67

6.3

3.4

59.4

57.7

0.41

138

(3030467) Casts [#/volume] in Urine by Automated count

321

1913

2.11

22.58

7.9

3.0

e6/l

0.2

0.5

1.74

280

1441

(3018095) Leukocytes [#/volume] in Urine

385

2460

2.06

22.37

9.8

3.6

e6/l

73.5

96.8

0.33

323

1750

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

8.55

22.37

1.9

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

8.55

22.37

1.9

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

342

2097

2.07

22.20

8.8

3.1

e6/l

28.1

61.3

1.84

306

1623

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

344

2116

2.07

22.12

3.5

2.1

u/l

119.2

224.3

2.16

333

1998

(3000494) Fungus identified in Specimen by Culture

186

896

2.39

22.02

2.9

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

257

1419

2.18

21.93

2.4

1.5

g/l

2.4

0.04

190

840

(40758558) Short blood count panel - Blood

302

1782

2.09

21.61

13.9

6.9

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

178

852

2.39

21.32

12.7

7.1

mmol/l

104.2

104.1

0.12

173

831

(36304419) Bacteria [Presence] in Urine

312

1872

2.07

21.28

7.8

3.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

187

917

2.34

21.18

5.3

4.5

33.4

32.3

0.67

146

619

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

197

3.73

21.07

1.7

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

207

3.66

21.03

3.4

2.2

mg/l

12.9

12.2

0.29

189

(3036489) Thrombin time

263

3.35

20.98

3.7

2.2

21.9

21.5

0.45

243

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

9.52

20.95

4.2

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

9.52

20.95

4.2

2.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

270

1547

2.11

20.74

11.4

4.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

6.52

20.68

2.2

1.8

41.0

37.8

—

(3026008) Bacteria identified in Urine by Culture

331

2048

2.03

20.58

4.4

2.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

342

2144

2.01

20.47

7.3

4.0

mg/mmol

23.2

7.3

3.90

252

1324

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

9.18

20.39

4.4

2.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

112

4.59

20.13

9.4

2.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

5.27

19.95

2.9

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

135

4.21

19.80

1.8

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

29.76

19.73

2.0

4.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

7.94

19.64

4.3

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

7.94

19.64

4.3

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

7.94

19.64

4.3

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

7.94

19.64

4.3

1.9

—

(3026782) Osmolality of Urine

242

1354

2.11

19.62

6.6

2.6

mosm/kgh2o

482.2

551.1

7.36

215

1164

(3028433) Virus identified in Specimen by Culture

9.12

19.50

1.2

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

396

2651

1.95

19.26

5.4

3.5

ng/l

999.0

50.7

0.49

326

1826

(4035726)

141

636

2.47

19.11

2.0

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

270

1594

2.03

18.80

1.8

1.5

nmol/l

19.2

21.3

1.44

240

1347

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

6.79

18.40

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

7.64

18.32

1.9

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

7.64

18.32

1.9

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

117

4.29

18.18

1.8

1.6

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

33.73

18.03

5.9

5.3

mg/l

2.4

2.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

178

3.62

18.02

14.7

2.8

mmol/l

23.2

25.1

2.46

157

(3051651) Icteric interference index of Serum or Plasma

6.32

17.76

4.4

3.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

157

767

2.29

17.68

8.1

8.3

kpa

5.0

5.1

1.46

148

741

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

214

1183

2.09

17.67

5.5

2.7

e6/l

0.6

1.0

3.29

165

671

(3003396) Base excess in Arterial blood by calculation

157

768

2.29

17.62

8.1

8.3

mmol/l

1.1

1.2

0.11

126

617

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

125

4.10

17.49

1.6

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

125

4.10

17.49

1.6

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

156

767

2.27

17.28

8.1

8.3

kpa

11.4

12.3

1.52

146

744

(3013512) EKG study

320

2053

1.91

17.16

5.3

3.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

147

711

2.30

16.90

4.5

3.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

107

4.29

16.72

1.8

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

145

3.76

16.41

2.7

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

176

3.47

16.15

1.8

1.7

e6/l

8445.3

14903.6

0.70

132

(3014111) Lactate [Moles/volume] in Serum or Plasma

130

608

2.35

16.11

11.2

7.6

mmol/l

1.4

1.3

0.10

121

587

(3015171) Extractable nuclear Ab [Units/volume] in Serum

262

3.00

16.00

1.5

1.2

u/ml

0.2

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

5.09

15.58

3.7

2.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

4.62

15.55

2.3

1.6

47.9

60.9

1.04

(3005322) IgE [Units/volume] in Serum or Plasma

105

457

2.49

15.23

1.6

1.2

u/ml

284.2

210.9

0.30

420

(3004616) Nuclear Ab [Presence] in Serum

4.51

15.10

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

210

3.16

15.10

4.5

2.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

189

3.28

15.09

1.4

1.2

u/ml

19.1

11.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

200

3.21

15.02

2.3

1.6

—

(3037756) Immunofixation for Serum or Plasma

145

3.61

14.91

2.2

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

122

3.84

14.78

3.6

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

5.78

14.69

3.0

2.0

10.3

14.3

0.64

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

187

3.26

14.68

1.4

1.2

u/ml

2.2

2.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

396

2.55

14.58

1.8

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

459

3405

1.78

14.58

8.4

3.5

estimate

0.0

0.00

612

(40768441) Liver Pathology biopsy report

5.15

14.40

2.6

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

463

3453

1.77

14.35

8.5

3.5

estimate

0.0

0.80

591

(3051611) Lipemic interference index of Serum or Plasma

4.85

14.34

4.5

3.0

—

(3021901) Oxygen saturation in Capillary blood

125

3.75

14.29

11.2

2.6

—

(3048689) Calprotectin [Mass/mass] in Stool

163

877

2.07

14.17

4.0

2.2

ug/g

181.2

113.4

0.83

136

701

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

192

3.17

14.06

4.9

3.9

—

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

147

3.48

13.89

5.1

4.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

255

1607

1.85

13.88

8.0

3.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

194

3.14

13.82

5.0

4.0

mg/l

58.0

86.6

0.39

155

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

194

3.14

13.82

5.0

4.0

mg/l

35.0

45.1

0.27

155

(3001964) Herpes simplex virus Ag [Presence] in Specimen

8.34

13.67

2.8

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

4.65

13.63

1.7

1.2

—

(3023419) Bacteria identified in Sputum by Culture

106

3.91

13.57

3.7

2.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

210

3.00

13.23

1.5

1.4

ug/g

257.7

295.8

0.71

124

(3021601) Nitrite [Presence] in Urine by Test strip

454

3416

1.73

13.19

10.8

4.8

estimate

0.0

0.50

622

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

150

803

2.06

13.15

10.6

2.7

umol/l

6.1

8.0

1.60

135

708

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

385

2779

1.72

12.91

2.4

1.9

pmol/l

98.3

96.8

0.24

225

1425

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

6.50

12.87

1.0

1.1

miu/ml

1671.9

1609.0

0.07

(40768804) Tissue Pathology biopsy report

385

2799

1.70

12.43

2.9

2.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

5.46

12.35

3.0

2.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

357

2.47

12.30

8.4

11.1

mmol/l

24.2

24.5

0.34

337

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

5.60

12.17

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

6.68

11.96

1.1

1.2

ratio

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

383

2.39

11.81

1.7

1.2

—

(40768443) Skin Pathology biopsy report

295

2.58

11.81

1.3

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

9.48

11.68

1.4

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

110

3.57

11.38

1.1

1.2

u/ml

2.1

6.2

1.09

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

229

2.75

11.31

2.3

2.6

g/l

8.4

10.6

3.25

199

(1616796) Gas panel - Central venous blood

141

3.24

11.27

7.0

3.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

8.02

11.04

5.0

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

4.74

11.00

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

221

2.75

10.97

1.5

1.6

—

(3021788) Differential panel - Synovial fluid

133

3.27

10.96

2.3

1.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

148

839

1.93

10.90

37.2

22.0

inr

1.5

1.2

1.20

110

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

4.66

10.77

1.2

—

(3017704) Immunofixation for Urine

5.67

10.74

1.3

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

3.69

10.73

1.8

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

184

2.89

10.68

2.3

1.3

—

(3003181) Sodium [Moles/volume] in Urine

115

3.42

10.65

2.0

1.2

mmol/l

59.6

63.5

0.20

102

(3023183) Ammonium ion [Moles/volume] in Plasma

157

3.04

10.62

4.7

3.6

umol/l

42.4

35.1

0.43

134

(3019060) Gas panel - Arterial blood

435

2.23

10.59

6.0

4.9

—

(3017732) Neutrophils [#/volume] in Blood

477

2.17

10.53

4.1

3.0

e9/l

4.7

4.1

1.09

380

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

2.60

10.50

2.5

g/l

3.1

3.7

4.04

185

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

2.60

10.50

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

2.60

10.50

2.5

g/l

7.2

7.4

0.34

194

(40767503) Oxygen content in Capillary blood by calculation

132

3.22

10.43

3.7

2.6

16.2

16.3

0.07

(3049717) Cytology report of Urine Cyto stain

251

2.59

10.42

2.7

2.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

4.05

10.10

1.4

1.3

e6/l

30865.9

137266.3

0.58

(3022145) Colonoscopy Study observation

139

791

1.91

10.08

1.6

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

265

1833

1.66

9.77

10.5

3.8

estimate

0.0

1.08

608

(3045424) Erythrocytes [Presence] in Urine

112

3.31

9.68

1.9

1.4

—

(3044927) Protein electrophoresis panel - Urine

3.88

9.56

1.3

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

17.77

9.42

12.2

5.4

mmol/l

5.8

6.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

215

2.62

9.40

3.3

2.8

g/l

0.3

1.0

1.15

194

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

6.62

9.38

2.1

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

4.13

9.30

2.8

2.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

159

2.87

9.20

3.3

2.3

g/l

127.8

130.9

0.32

118

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

237

2.51

9.08

2.6

2.5

g/l

3.2

3.1

0.20

188

(3010421) pH of Blood

155

2.87

9.04

7.6

3.4

7.4

0.87

128

(3009214) Lutropin [Units/volume] in Serum or Plasma

179

2.72

8.92

1.4

1.5

u/l

14.5

9.7

0.80

145

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

313

2300

1.58

8.81

8.3

3.3

u/l

29.9

32.2

0.98

300

2191

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

765

7004

2.21

8.69

46.1

13.7

mg/l

19.9

22.9

1.72

713

5493

(3012501) Base excess in Blood by calculation

131

2.99

8.65

6.7

3.5

mmol/l

2.2

2.6

0.31

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

175

1118

1.72

8.57

6.8

2.9

e6/l

1.5

2.3

0.80

126

613

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

121

3.06

8.56

1.4

1.3

—

(3021589) Normoblasts [#/volume] in Blood

402

3143

1.54

8.50

23.8

9.2

e9/l

0.0

0.19

355

2567

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

107

3.17

8.33

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

199

2.55

8.21

2.5

2.7

g/l

37.8

37.7

0.02

174

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

208

1405

1.64

8.21

1.5

1.7

pmol/l

40230313.3

14088586.6

0.28

174

1157

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

362

2.15

8.13

9.4

10.9

—

(40757373) Influenza virus identified in Isolate

7.15

8.01

3.2

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

7.95

8.00

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

7.95

8.00

2.4

1.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

105

3.13

7.93

1.1

1.2

u/ml

2.8

3.9

0.19

(3008152) Bicarbonate [Moles/volume] in Arterial blood

424

2.04

7.79

9.7

7.4

mmol/l

24.5

24.6

0.07

397

(3020393) Adenovirus Ag [Presence] in Stool

15.19

7.73

3.1

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.80

7.66

1.1

—

(1761868) Lipid panel - Serum or Plasma

175

2524

0.61

7.61

3.5

2.9

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

8.42

7.59

1.2

85.3

94.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

8.42

7.59

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

7.42

7.57

1.2

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

5.68

7.56

1.3

1.2

g/l

38.4

38.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

138

854

1.74

7.51

11.4

6.7

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

3.99

7.19

3.4

2.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

4.78

7.19

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

186

1260

1.61

7.15

1.4

1.3

iu/ml

62.0

33.8

0.84

404

(3020891) Body temperature

258

2.26

7.14

9.9

4.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

7.77

7.13

1.8

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.62

6.90

1.5

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

569

1.84

6.89

2.9

2.4

ug/l

10.2

7.4

0.49

507

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

3.24

6.89

1.3

1.1

u/l

168.8

56.9

0.89

(3024891) Influenza virus A+B Ag [Presence] in Specimen

170

2.49

6.62

1.6

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

5.78

6.60

1.8

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

3.70

6.50

1.4

1.1

titre

418.6

104.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

491

1.86

6.42

2.2

1.6

—

(3045414) Leukocytes [Presence] in Urine

291

2.11

6.38

2.1

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.52

6.30

2.3

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

3.89

6.28

2.4

1.2

—

(4268621)

3.26

6.18

1.9

2.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

540

4659

1.46

6.07

7.3

3.2

u/l

70.2

50.0

1.82

512

4355

(3024928) Oxygen saturation in Venous blood

165

2.43

6.05

13.2

2.7

—

(3042631) Mycobacterium sp identified in Specimen

2.98

6.04

2.0

2.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

2.95

5.93

3.4

2.5

mg/l

14.4

22.7

—

(3014271) Vancomycin [Susceptibility]

4.23

5.84

2.4

2.3

—

(4010399)

538

1.78

5.78

1.9

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.96

5.73

1.1

1.0

—

(3008898) HLA-B27 [Presence]

256

2.10

5.67

1.2

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

3.16

5.65

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

4.11

5.64

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

4.11

5.64

1.1

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

104

647

1.69

5.52

5.7

2.4

u/l

41.0

35.2

0.42

558

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

3.39

5.47

3.2

2.9

46.2

39.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.00

5.46

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

16.14

5.42

2.0

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

610

0.39

5.40

1.6

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

143

2.44

5.37

1.4

1.2

u/ml

69.2

29.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

181

1294

1.51

5.36

5.7

3.9

ng/l

357.6

366.0

0.02

144

998

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

113

2.62

5.35

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.33

5.33

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.05

5.27

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

171

1212

1.52

5.26

1.3

u/ml

29.5

13.4

0.93

463

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

+∞

5.21

2.2

0.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

4.24

5.10

3.1

1.3

2.8

2.0

—

(40768797) Stomach Pathology biopsy report

145

998

1.55

5.10

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.01

5.01

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.53

4.91

1.1

1.0

—

(3002256) Pathology report gross observation

132

897

1.56

4.91

1.4

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

107

2.57

4.84

2.3

2.5

u/ml

16.0

41.0

0.29

102

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

425

0.32

4.81

1.5

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

9.08

4.79

1.9

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

9.08

4.79

1.9

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

9.08

4.79

1.9

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

159

2.25

4.68

1.6

1.2

mmol/l

3.8

3.9

0.14

148

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

103

2.57

4.67

1.6

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

3.15

4.66

1.7

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

8.26

4.57

2.4

1.4

—

(3019174) dRVVT (LA screen)

10.08

4.52

1.0

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

136

2.33

4.50

1.6

1.3

—

(4306422)

105

2.52

4.50

1.1

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

445

1.73

4.46

1.3

—

42.3

—

(3011648) Oxygen content in Venous blood

3.04

4.42

17.2

2.1

11.4

11.2

0.06

(3026389) Candida sp identified in Specimen by Organism specific culture

2.63

4.17

1.2

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

4.39

4.09

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

10.07

4.01

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

6.49

3.99

2.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

318

2632

1.34

3.91

9.9

3.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

165

1230

1.43

3.86

3.2

3.1

mmol/l

2.5

1.31

146

1085

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

488

1.64

3.84

2.4

—

16.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

8.81

3.78

9.4

4.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

8.81

3.78

1.0

1.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.57

3.77

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

3.37

3.77

1.2

1.0

u/l

0.9

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

421

1.67

3.71

2.3

3.0

pmol/l

4.2

4.6

2.06

369

(4015189)

5.67

3.66

1.3

2.7

—

(3047181) Lactate [Moles/volume] in Blood

212

1.93

3.64

7.7

6.4

mmol/l

1.3

0.15

188

(3016650) Hepatitis A virus Ab [Presence] in Serum

123

2.24

3.64

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

196

1521

1.38

3.62

10.7

3.7

kg/l

1.0

0.57

211

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.64

3.49

1.2

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.42

3.41

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

210

1.90

3.41

1.5

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

3.19

3.22

1.2

1.1

u/l

179.8

610.7

0.81

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.36

3.20

1.6

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.36

3.20

1.6

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

111

2.20

3.15

3.1

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

211

1.84

3.05

1.6

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

517

1.54

3.05

2.7

2.1

nmol/l

12.7

13.0

0.13

469

(42529406) Shigella sp [Presence] in Stool by Culture

214

1.81

2.93

1.6

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

2.53

2.88

1.7

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.42

2.87

1.1

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

6.70

2.87

2.2

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

6.70

2.87

1.0

1.4

—

(4027681)

2.96

2.86

1.3

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.96

2.86

7.6

3.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

116

2.10

2.85

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.08

2.81

1.5

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

195

1.83

2.80

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.48

2.80

1.6

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.94

2.78

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

8.37

2.75

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.03

2.73

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.45

2.72

1.2

1.4

—

(3044889) 12 lead EKG panel

453

4993

0.80

2.70

5.5

3.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.03

2.70

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

100

727

1.43

2.69

3.0

4.4

ug/l

10.8

26.1

0.66

609

(3010838) Calcium [Moles/time] in 24 hour Urine

2.82

2.65

2.8

1.6

—

11.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

120

2.03

2.63

1.3

1.1

u/ml

4.1

1.9

0.22

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

2.57

2.62

1.7

1.1

u/ml

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

196

1594

1.30

2.58

1.4

1.3

u/ml

3.3

1.8

0.49

414

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

4.03

2.57

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

4.03

2.57

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

4.03

2.57

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

4.03

2.57

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

481

4354

1.25

2.56

3.3

2.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.25

2.55

3.3

3.9

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

7.18

2.55

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.49

2.54

1.3

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

108

2.07

2.53

1.2

1.0

u/ml

2.3

7.2

1.53

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

4.40

2.48

1.3

1.1

—

(3047189) Immunofixation for 24 hour Urine

2.96

2.42

2.9

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

5.03

2.40

1.5

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

161

1.83

2.38

1.7

2.0

u/l

166.8

4108.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

6.28

2.37

1.6

2.6

—

(44806071)

6.28

2.37

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

6.28

2.37

1.0

1.4

—

(21494755) Public health laboratory ask at order entry panel

640

0.62

2.33

1.2

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.88

2.31

2.9

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

548

5872

0.80

2.30

46.7

16.9

14.4

13.6

23.67

539

5757

(3034426) Prothrombin time (PT)

3.50

2.27

1.0

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

755

7273

1.43

2.27

46.4

15.7

mmol/l

139.5

139.7

1.72

735

7094

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.36

2.22

1.5

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

195

1.72

2.22

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.22

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.58

2.21

2.8

1.4

umol/l

54.8

38.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

756

7289

1.43

2.21

47.5

15.8

mmol/l

4.0

1.32

735

7098

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.31

2.15

1.5

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

4.31

2.15

14.2

1.9

mmol/l

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

4.31

2.15

7.0

2.6

—

(3045142) Bone marrow Pathology biopsy report

2.16

2.09

2.3

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.42

2.03

2.0

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

577

5393

1.23

2.02

4.7

3.9

pmol/l

15.0

14.8

1.33

532

4904

(3001019) Free T4 and TSH panel - Serum or Plasma

348

0.54

1.99

1.4

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.30

1.98

1.2

1.1

—

(4034850)

226

1.62

1.96

13.2

9.6

—

(40758292) HTLV I+II Ab panel - Serum

4.57

1.94

1.2

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

217

1847

1.24

1.92

8.1

3.2

—

(3008295) Osmolality of Serum or Plasma

2.07

1.92

1.4

mosm/kgh2o

283.2

279.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

3.55

1.84

15.5

1.7

mmol/l

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

4.19

1.82

1.4

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.28

1.81

1.8

1.5

u/l

9.8

8.1

—

(3000492) Spirometry study

708

1.34

1.81

2.0

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

131

1.78

1.79

1.8

3.0

nmol/l

1.0

0.8

0.48

101

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.36

1.78

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

347

1.47

1.78

2.5

2.3

—

(1002224) Polysomnography panel

295

0.53

1.74

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

103

1.86

1.73

1.2

1.0

u/ml

1.7

1.8

—

(36660697) Celiac disease serology panel - Serum

581

1.36

1.72

1.2

—

(3033799) Differential panel - Peritoneal fluid

2.93

1.72

1.4

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

475

0.64

1.68

1.2

—

(3044941) Cell count panel - Synovial fluid

119

1.78

1.67

1.7

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.81

1.65

4.1

4.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.81

1.65

3.3

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.26

1.64

3.5

1.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.16

1.61

2.8

1.8

—

(21494434) Karyotype in Bone marrow

2.08

1.60

1.6

1.2

—

(3006462) Nitrate [Presence] in Urine

2.51

1.60

2.0

3.3

—

(40761536) Microorganisms panel - Urine sediment

572

1.34

1.58

9.7

3.8

—

(4146454)

1.94

1.55

3.0

2.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.44

1.54

2.8

2.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

106

854

1.28

1.52

2.2

1.8

1.5

0.50

752

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.87

1.50

1.2

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1.92

1.50

10.3

2.1

34.0

32.7

0.66

(3051593) INR in Capillary blood by Coagulation assay

2.51

1.45

7.7

9.9

—

(3048879) Bone marrow aspiration report

3.14

1.44

3.2

2.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.74

1.43

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.43

1.39

2.6

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

692

6672

1.23

1.39

32.7

12.7

ml/min/173m2

72.7

81.7

14.32

628

5467

(3003740) Influenza virus B Ag [Presence] in Specimen

104

1.75

1.38

1.5

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

2.21

1.37

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.62

1.37

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.16

1.34

2.3

1.7

—

(40768800) Prostate Pathology biopsy report

146

0.48

1.33

1.0

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.51

1.30

1.3

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.51

1.30

1.3

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.10

1.30

2.3

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

2.37

1.29

1.1

1.3

nmol/l

157.1

159.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.95

1.28

1.8

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

146

1700

0.83

1.27

3.6

4.2

23.2

20.8

1.12

789

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.30

1.27

1.0

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.06

1.27

1.6

1.5

—

23.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

278

1.42

1.27

3.2

3.4

u/ml

23.1

4652.6

0.71

238

(3003694) ABO and Rh group [Type] in Blood

212

1871

1.18

1.26

1.5

1.4

—

(40765096) Chromosome analysis panel by Banding

2.41

1.24

1.5

1.0

—

(3000012) Reticulocyte production index

2.23

1.24

1.5

2.0

—

(4211845)

2.23

1.24

2.0

3.0

—

(40768806) Pleura Pathology biopsy report

1.92

1.23

1.3

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1.81

1.21

1.1

1.0

u/ml

16.6

5.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1.81

1.21

1.4

1.5

pmol/l

327.0

308.1

—

(4094501)

199

0.55

1.19

1.1

—

(3022621) pH of Urine by Test strip

456

1.32

1.19

4.1

2.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

102

1.68

1.17

1.2

1.0

u/ml

1.4

3.9

—

(40761511) CBC panel - Blood by Automated count

751

7332

1.26

1.15

38.3

12.9

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.51

1.15

37.4

6.6

—

(3012441) Differential panel - Pleural fluid

1.91

1.12

1.6

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.27

1.10

1.7

1.2

ug/l

11.5

8.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

140

0.50

1.09

1.0

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

767

7513

1.28

1.09

30.8

10.5

u/l

25.9

26.8

0.84

746

7270

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.39

1.09

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

177

1.48

1.09

5.3

2.4

ug/min

39.6

77.1

0.75

103

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.93

1.06

5.6

2.0

u/field

0.6

2.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

146

1.52

1.04

1.7

1.3

—

(40768793) Breast Pathology biopsy report

188

0.58

1.00

1.6

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.68

0.98

1.1

1.0

u/ml

8.4

2.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

221

1995

1.15

0.98

1.9

1.7

mmol/l

1.5

1.4

1.36

195

1682

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.95

0.97

1.0

—

(3045788) Cell count panel - Pleural fluid

1.86

0.97

2.1

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

107

1248

0.84

0.97

2.9

3.0

ug/l

0.7

0.06

811

(3005570) Glucose [Moles/volume] in Urine

1.70

0.95

1.5

2.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

261

1.36

0.93

1.5

iu/l

30.9

27.7

0.13

227

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.08

0.89

1.7

3.1

u/l

291.7

199.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.01

0.87

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

105

1.53

0.82

1.6

1.1

—

(3023410) Appearance of Cerebral spinal fluid

1.63

0.78

1.9

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

186

0.64

0.77

2.3

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

125

1.45

0.73

1.7

1.6

—

(40768795) Lymph node Pathology biopsy report

1.63

0.72

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

670

6535

1.13

0.71

8.8

5.7

mmol/mol

40.1

39.7

0.47

620

6079

(3028300) Cannabinoids [Presence] in Urine

217

0.69

0.71

1.3

1.5

—

(3027008) Opiates [Presence] in Urine

217

0.69

0.71

1.3

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

662

6454

1.13

0.70

5.8

4.7

mu/l

1.9

2.1

0.35

615

5905

(3011288) Drugs identified in Urine by Screen method

144

0.62

0.70

1.2

2.0

—

(3024263) Appearance of Synovial fluid

1.71

0.70

2.7

1.5

—

(3027944) Amphetamines [Presence] in Urine

216

0.69

1.3

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

215

0.69

0.68

1.3

1.5

—

(3044007) Cell count panel - Peritoneal fluid

1.79

0.66

2.6

2.0

—

(3016879) Cocaine [Presence] in Urine

201

0.69

0.65

1.4

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

173

1.34

0.62

2.7

1.8

iu/l

2.6

4.8

—

(3025130) Human papilloma virus identified in Specimen

1.56

0.62

1.9

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

628

6427

0.91

0.58

36.7

14.9

37.0

39.9

9.39

417

4646

(3000963) Hemoglobin [Mass/volume] in Blood

775

7832

0.84

0.57

61.5

20.4

g/l

128.5

135.8

30.52

761

7727

(3010813) Leukocytes [#/volume] in Blood

775

7829

0.84

0.54

61.4

20.3

e9/l

7.4

6.6

15.26

757

7615

(3026361) Erythrocytes [#/volume] in Blood

775

7829

0.84

0.54

61.3

20.3

e12/l

4.3

4.5

21.27

757

7614

(3004716) Salmonella sp identified in Stool by Organism specific culture

368

1.21

0.54

1.6

1.3

—

(3035941) MCH [Entitic mass]

775

7828

0.84

0.53

60.9

20.2

30.2

30.3

0.41

761

7726

(3024731) MCV [Entitic volume]

775

7827

0.85

0.52

61.0

20.2

92.1

91.0

7.79

761

7725

(3007461) Platelets [#/volume] in Blood

775

7825

0.85

0.50

61.5

20.3

e9/l

259.9

251.9

2.28

759

7632

(1001926) Buprenorphine [Presence] in Urine by Screen method

167

0.71

0.49

1.4

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

271

1.23

0.49

1.5

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

701

7119

0.90

0.49

6.4

5.0

mmol/l

2.6

2.8

8.78

647

6583

(1761482) Bacteria [#/volume] in Urine by Culture

177

0.73

0.47

6.9

4.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

233

0.77

0.47

2.3

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

218

1.25

0.47

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1091

0.89

0.46

1.5

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.64

0.42

1.2

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.41

0.42

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.41

0.42

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.41

0.42

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.38

0.41

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.38

0.41

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.38

0.41

1.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.41

0.0

1.0

—

25.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.41

0.0

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

227

0.79

0.40

1.8

1.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.40

0.0

1.3

—

0.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

214

1.22

0.40

1.7

nmol/l

36.2

40.3

0.51

207

(3047007) Chlamydophila sp Ab [Presence] in Serum

106

1.33

0.39

1.2

—

(44806420)

0.00

0.39

0.0

2.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

3.6

—

(3017569) Oxygen content in Arterial blood

1.39

0.38

2.2

3.9

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.33

0.37

1.2

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

179

1.24

0.37

1.1

1.3

miu/ml

206.2

225.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

115

0.69

0.37

2.0

1.5

—

(3004451) EKG impression Narrative

1.35

0.37

1.6

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.28

0.32

1.2

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

100

0.70

0.30

1.1

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1.31

0.30

1.4

1.6

ug/l

14.2

18.6

1.39

(3014051) Protein [Presence] in Urine by Test strip

148

1.22

0.29

2.3

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

638

0.90

0.29

2.2

1.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

617

0.90

0.29

1.6

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

109

0.73

0.29

1.3

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

150

1.20

0.26

1.8

pmol/l

197.1

216.1

0.37

140

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

104

1.25

0.26

1.1

1.0

u/ml

7.6

2.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.74

0.24

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.72

0.24

1.3

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

115

1.22

0.23

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

472

0.91

0.22

1.2

iu/ml

60.7

125.1

1.29

198

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

10.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.16

0.21

1.2

3.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.16

0.21

1.2

1.4

ug/l

5.1

6.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.24

0.21

3.5

2.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.21

0.0

1.0

—

(44813793)

1.20

0.19

1.5

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

1.23

0.19

3.5

2.6

mmol/l

4.2

4.0

0.36

(3035285) Chloride [Moles/volume] in Venous blood

1.23

0.19

3.5

2.6

mmol/l

106.1

105.0

0.65

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1.15

0.19

1.0

1.1

—

9.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

684

6895

0.95

0.18

6.8

4.6

mmol/l

5.9

0.69

635

6310

(4024509)

1.16

0.16

1.1

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

677

6719

1.04

0.16

5.8

4.0

mmol/l

1.5

1.3

9.76

622

6173

(3005033) Fetal Nuchal fold Thickness US

0.75

0.15

1.3

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

182

0.88

0.15

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

102

1.18

0.15

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.80

0.14

1.9

1.3

nmol/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

243

0.90

0.14

1.4

1.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

0.83

0.13

1.8

1.2

nmol/l

100.5

0.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.82

0.13

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.82

0.13

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.81

0.13

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.81

0.13

1.4

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

106

0.85

0.13

1.4

1.6

—

(3000330) Specific gravity of Urine by Test strip

334

0.93

0.12

4.8

3.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

300

0.93

0.10

1.4

1.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

776

1.03

0.08

1.5

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

108

1.11

0.07

1.0

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

696

6986

0.98

0.07

6.2

4.5

mmol/l

4.6

4.7

2.69

646

6484

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.84

0.06

1.8

1.2

—

0.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

120

1223

0.98

0.06

1.6

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

149

1.08

0.05

4.7

3.6

mg/l

21.1

22.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

694

6954

0.99

0.03

6.2

4.4

mmol/l

1.5

0.19

643

6424

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

209

2104

0.99

0.02

4.1

4.7

ug/l

1.9

2.3

1.16

181

1902

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

113

1.06

0.02

1.8

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

362

1.02

0.01

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

574

0.99

0.00

2.1

1.8

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.93

0.00

1.3

2.2

13.4

13.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

4.8

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.0

2.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.90

0.00

1.8

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.3

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.0

1.2

—

77.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

6.6

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

2.0

—

1.8

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.0

1.5

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

2.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.0

5.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.88

0.00

1.2

mmol/l

8.7

6.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.0

1.7

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.0

—

7.8

—

(3013762) Body weight Measured

0.00

0.0

1.8

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint DRUGADVERS_CATAR and mortality.

Females

Parameter	HR [95% CI]	p-value
DRUGADVERS_CATAR	3.266 [2.86, 3.73]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.061

During the follow-up period (1.1.1998 — 31.12.2019), 634 out of 2151 females with DRUGADVERS_CATAR died.

Males

Parameter	HR [95% CI]	p-value
DRUGADVERS_CATAR	3.542 [3.09, 4.06]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 578 out of 1606 males with DRUGADVERS_CATAR died.

Mortality risk

Mortality risk for people of age

years, who have DRUGADVERS_CATAR.

N-year risk	Females	Males
1	0.22%	0.562%
5	2.003%	3.4%
10	4.599%	9.293%
15	8.461%	17.053%
20	13.692%	27.482%

Relationships between endpoints

↥

Index endpoint: DRUGADVERS_CATAR – Drug-induced cataract

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Drug-induced cataract

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints